WallStSmart

Kewaunee Scientific Corporation (KEQU)vsSea Ltd (SE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sea Ltd generates 9731% more annual revenue ($27.72B vs $282.00M). SE leads profitability with a 5.9% profit margin vs 3.4%. KEQU trades at a lower P/E of 11.4x. SE earns a higher WallStSmart Score of 56/100 (C).

KEQU

Hold

38

out of 100

Grade: F

Growth: 3.3Profit: 6.0Value: 5.7Quality: 7.5
Piotroski: 3/9Altman Z: 3.28

SE

Buy

56

out of 100

Grade: C

Growth: 8.7Profit: 5.5Value: 6.7Quality: 6.5
Piotroski: 6/9Altman Z: 1.53
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KEQUSignificantly Overvalued (-18.1%)

Margin of Safety

-18.1%

Fair Value

$33.69

Current Price

$34.45

$0.76 premium

UndervaluedFair: $33.69Overvalued
SEUndervalued (+56.1%)

Margin of Safety

+56.1%

Fair Value

$260.75

Current Price

$106.24

$154.51 discount

UndervaluedFair: $260.75Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KEQU3 strengths · Avg: 10.0/10
P/E RatioValuation
11.4x10/10

Attractively priced relative to earnings

Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
3.2810/10

Safe zone — low bankruptcy risk

SE3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
48.1%10/10

Revenue surging 48.1% year-over-year

Market CapQuality
$65.07B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.15B8/10

Generating 1.1B in free cash flow

Areas to Watch

KEQU4 concerns · Avg: 2.8/10
Market CapQuality
$105.56M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
3.4%3/10

3.4% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-7.5%2/10

Revenue declined 7.5%

SE3 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Profit MarginProfitability
5.9%3/10

5.9% margin — thin

P/E RatioValuation
41.5x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : KEQU

The strongest argument for KEQU centers on P/E Ratio, Price/Book, Altman Z-Score.

Bull Case : SE

The strongest argument for SE centers on Revenue Growth, Market Cap, Free Cash Flow. Revenue growth of 48.1% demonstrates continued momentum. PEG of 1.04 suggests the stock is reasonably priced for its growth.

Bear Case : KEQU

The primary concerns for KEQU are Market Cap, Profit Margin, Piotroski F-Score. Thin 3.4% margins leave little buffer for downturns.

Bear Case : SE

The primary concerns for SE are Altman Z-Score, Profit Margin, P/E Ratio. A P/E of 41.5x leaves little room for execution misses.

Key Dynamics to Monitor

KEQU profiles as a value stock while SE is a hypergrowth play — different risk/reward profiles.

SE carries more volatility with a beta of 1.52 — expect wider price swings.

SE is growing revenue faster at 48.1% — sustainability is the question.

SE generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

SE scores higher overall (56/100 vs 38/100) and 48.1% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kewaunee Scientific Corporation

CONSUMER CYCLICAL · FURNISHINGS, FIXTURES & APPLIANCES · USA

Kewaunee Scientific Corporation designs, manufactures and installs laboratory, sanitary and technical furniture products. The company is headquartered in Statesville, North Carolina.

Sea Ltd

CONSUMER CYCLICAL · INTERNET RETAIL · USA

Sea Limited is engaged in the digital entertainment, e-commerce and digital financial services businesses in Southeast Asia, Latin America, the rest of Asia and internationally. The company is headquartered in Singapore.

Want to dig deeper into these stocks?